Geoff Schweller

1 week ago | whistleblowersblog.org | Geoff Schweller

While the whistleblower program administered by U.S. Securities and Exchange Commission (SEC) is often heralded as the gold standard of whistleblower programs, advocates and members of Congress believe there is still need for reform. In a new article for the NYU Law Compliance & Enforcement blog, leading whistleblower attorney Stephen M. Kohn of Kohn, Kohn & Colapinto outlines the needed reforms found in the bipartisan SEC Whistleblower Reform Act.

1 week ago | whistleblowersblog.org | Geoff Schweller

On May 1, the U.S. Department of Justice (DOJ) announced that Raytheon Company (Raytheon), RTX Corporation, and Nightwing Group LLC, and Nightwing Intelligence Solutions LLC (collectively, Nightwing), have agreed to pay $8.4 million to resolve whistleblower allegations that Raytheon violated the False Claims Act by failing to comply with cybersecurity requirements in contracts or subcontracts with the Department of Defense (DoD).

1 week ago | whistleblowersblog.org | Geoff Schweller

On May 2, Judge Beryl A. Howell of the U.S. District Court for the District of Columbia issued a ruling striking down President Trump’s Executive Order targeting the law firm Perkins Coie. The decision found the Executive Order unconstitutional and labeled it “an unprecedented attack” on foundational principles of the American judicial system.

2 weeks ago | whistleblowersblog.org | Geoff Schweller

According to new polling, 86% of Australians want stronger legal protections for whistleblowers. The polling research was conducted by the Australia Institute and supported by Human Rights Law Centre and Whistleblower Justice Fund. The polling shows that the overwhelming support for whistleblowers remains consistent across political affiliations and the support for increased protections has increased by 13% since a similar poll was conducted in 2021.

2 weeks ago | whistleblowersblog.org | Geoff Schweller

On April 23, the U.S. Attorney for the Eastern District of Pennsylvania announced that genetic testing marketing companies Genexe, LLC, Immerge, Inc., and two executives with ownership interests in the companies, agreed to pay $6 million to resolve allegations that they violated the False Claims Act through a fraud scheme involving illegal kickbacks and medically unnecessary genetic tests charged to Medicare.